Search research articles
Contact Us
Filters
Showing results (101-110 of 584) with videos related to
Page
of 59
Sort By:
Therapeutic Drug Monitoring
|
June 1, 1983
Decreased rate of creatinine production in patients with hepatic disease: implications for estimation of creatinine clearance
D M Cocchetto, C Tschanz, T D Bjornsson
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
November 25, 2010
Thymic epithelial tumours in Iceland: incidence and histopathology, a population-based study
Elin Mariusdottir, Sigfus Nikulasson, Johannes Bjornsson, et al.
Journal of Clinical Pharmacology
|
February 1, 1983
Plasma dipyridamole concentrations after two different dosage regimens in patients
C Mahony, J L Cox, T D Bjornsson
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1989
Aspirin acetylates fibrinogen and enhances fibrinolysis. Fibrinolytic effect is independent of changes in plasminogen activator levels
T D Bjornsson, D E Schneider, H Berger
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
July 1, 1993
Labetalol therapy in pregnancy induced hypertension: the effects on fetoplacental circulation and fetal outcome
T Z Mahmoud, S Bjornsson, A A Calder
Studies in Health Technology and Informatics
|
June 15, 2010
Risk assessment of integrated electronic health records
Bjarni Thor Bjornsson, Gudlaug Sigurdardottir, Stefan Orri Stefansson
Journal of Psychiatric Practice
|
May 9, 2013
Cued panic attacks in body dysmorphic disorder
Katharine A Phillips, William Menard, Andri S Bjornsson
Mayo Clinic Proceedings
|
February 1, 1985
Hematopoietic cells in thyroid fine-needle aspirates for cytologic study: report of two cases
J D Gay, J Bjornsson, J R Goellner
Scandinavian Journal of Gastroenterology
|
November 23, 2020
Acute upper gastrointestinal bleeding: a population-based, five-year follow-up study
Johann P Hreinsson, Armann Jonsson, Einar S Bjornsson
Hepatology (Baltimore, Md.)
|
October 20, 2009
Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events
Craig Lammert, Einar Bjornsson, Anna Niklasson, et al.
Page
of 59
Search research articles
Search
Showing results (101-110 of 584) with videos related to
Sort By:
Page
of 59
Therapeutic Drug Monitoring
|
June 1, 1983
Decreased rate of creatinine production in patients with hepatic disease: implications for estimation of creatinine clearance
D M Cocchetto, C Tschanz, T D Bjornsson
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
November 25, 2010
Thymic epithelial tumours in Iceland: incidence and histopathology, a population-based study
Elin Mariusdottir, Sigfus Nikulasson, Johannes Bjornsson, et al.
Journal of Clinical Pharmacology
|
February 1, 1983
Plasma dipyridamole concentrations after two different dosage regimens in patients
C Mahony, J L Cox, T D Bjornsson
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1989
Aspirin acetylates fibrinogen and enhances fibrinolysis. Fibrinolytic effect is independent of changes in plasminogen activator levels
T D Bjornsson, D E Schneider, H Berger
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
July 1, 1993
Labetalol therapy in pregnancy induced hypertension: the effects on fetoplacental circulation and fetal outcome
T Z Mahmoud, S Bjornsson, A A Calder
Studies in Health Technology and Informatics
|
June 15, 2010
Risk assessment of integrated electronic health records
Bjarni Thor Bjornsson, Gudlaug Sigurdardottir, Stefan Orri Stefansson
Journal of Psychiatric Practice
|
May 9, 2013
Cued panic attacks in body dysmorphic disorder
Katharine A Phillips, William Menard, Andri S Bjornsson
Mayo Clinic Proceedings
|
February 1, 1985
Hematopoietic cells in thyroid fine-needle aspirates for cytologic study: report of two cases
J D Gay, J Bjornsson, J R Goellner
Scandinavian Journal of Gastroenterology
|
November 23, 2020
Acute upper gastrointestinal bleeding: a population-based, five-year follow-up study
Johann P Hreinsson, Armann Jonsson, Einar S Bjornsson
Hepatology (Baltimore, Md.)
|
October 20, 2009
Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events
Craig Lammert, Einar Bjornsson, Anna Niklasson, et al.
Page
of 59